Skip to main content
SpringerLink
Log in

Serum hepatitis B virus DNA level as a risk predictor for liver disease complications

  • Practice Point
  • Published:

From Nature Clinical Practice Gastroenterology & Hepatology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. EASL Jury (2003) EASL International Consensus Conference on Hepatitis B: 13–14 September, 2002: Geneva, Switzerland. Consensus statement (short version). J Hepatol 38: 533–540

  2. Brechot C (2004) Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 127 (Suppl 1): S56–S61

    Article  CAS  Google Scholar 

  3. Iloeje UH et al. (2006) Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 130: 678–686

    Article  Google Scholar 

  4. Hadziyannis SJ et al. (2005) Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B. N Engl J Med 352: 2673–2681

    Article  CAS  Google Scholar 

  5. Lai CL et al. (2006) Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med 354: 1011–1020

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. practicing clinician and research group leader,

    Frank Tacke & Christian Trautwein

  2. Head and Chairman of the Medical Clinic III at the University Hospital Aachen, Aachen, Germany

    Frank Tacke & Christian Trautwein

Authors
  1. Frank Tacke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christian Trautwein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christian Trautwein.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tacke, F., Trautwein, C. Serum hepatitis B virus DNA level as a risk predictor for liver disease complications. Nat Rev Gastroenterol Hepatol 3, 426–427 (2006). https://doi.org/10.1038/ncpgasthep0561

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0561

  • Springer Nature Limited

Search

Navigation